These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10866348)

  • 21. Temozolomide for refractory anaplastic astrocytoma.
    Med Lett Drugs Ther; 1999 Dec; 41(1068):123-4. PubMed ID: 10987014
    [No Abstract]   [Full Text] [Related]  

  • 22. Temozolomide as first-line agent in treating high-grade gliomas: phase II study.
    Chibbaro S; Benvenuti L; Caprio A; Carnesecchi S; Pulerà F; Faggionato F; Serino D; Galli C; Andreuccetti M; Buxton N; Gagliardi R
    J Neurooncol; 2004; 67(1-2):77-81. PubMed ID: 15072451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 25. Temozolomide-induced flare in high-grade gliomas: a new clinical entity.
    Rosenthal MA; Ashley DL; Cher L
    Intern Med J; 2002 Jul; 32(7):346-8. PubMed ID: 12088355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of adjuvant chemotherapy in high-grade gliomas.
    DeAngelis LM
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral temozolomide approved for refractory brain tumor.
    Miller JL
    Am J Health Syst Pharm; 1999 Oct; 56(19):1910. PubMed ID: 10554903
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of temozolomide in malignant brain tumours.
    Osoba D
    Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071219
    [No Abstract]   [Full Text] [Related]  

  • 29. The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors.
    Friedman HS; Keir ST; Houghton PJ
    Cancer; 2003 May; 97(9 Suppl):2359-62. PubMed ID: 12712457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temozolomide: realizing the promise and potential.
    Nagasubramanian R; Dolan ME
    Curr Opin Oncol; 2003 Nov; 15(6):412-8. PubMed ID: 14624222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting enhances the response of glioma to chemo- and radiotherapy.
    Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
    PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
    Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
    J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of patients with recurrent malignant glioma treated with temozolomide: a retrospective observational study.
    Trippoli S; Pelagotti F; Messori A; Vacca F; Vaiani M; Maltoni S
    Drugs R D; 2003; 4(5):285-91. PubMed ID: 12952497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy.
    Gilbert MR; Friedman HS; Kuttesch JF; Prados MD; Olson JJ; Reaman GH; Zaknoen SL
    Neuro Oncol; 2002 Oct; 4(4):261-7. PubMed ID: 12356356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas.
    Motomura K; Natsume A; Wakabayashi T
    J Neurooncol; 2012 Jan; 106(1):209-11. PubMed ID: 21725854
    [No Abstract]   [Full Text] [Related]  

  • 36. Temozolomide: a milestone in the pharmacotherapy of brain tumors.
    Weller M; Steinbach JP; Wick W
    Future Oncol; 2005 Dec; 1(6):747-54. PubMed ID: 16556052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.
    Bower M; Newlands ES; Bleehen NM; Brada M; Begent RJ; Calvert H; Colquhoun I; Lewis P; Brampton MH
    Cancer Chemother Pharmacol; 1997; 40(6):484-8. PubMed ID: 9332462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic astrocytoma in adults.
    Stupp R; Reni M; Gatta G; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2007 Jul; 63(1):72-80. PubMed ID: 17478095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
    Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of temozolomide using an extended continuous oral schedule.
    Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
    Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.